Podcasts about prax

Ako púšťať emócie a pracovať s telom i mysľou? Zbaviť sa úzkosti, depresie, zmierniť epilepsiu? Dá sa to majstrovsky? Ako sa zbaviť traumy metódou TRE? Teda trasením tela? Link na web: https://www.metoda-tre.sk/ kupón VYHODNE pre lepšiu cenu v pokladni...Aj keď to môže znieť zvláštne, ide o uznávanú metódu známu aj v zahraničí. Dnes sa budem rozprávať s vyštudovanou biologičkou so zameraním na fyziológiu, RNDr. Evou TóthOtázky na hosťa: Vy sa venujete Metóde TRE® naplno z hľadiska vedeckého aj praktického. O akú metódu vlastne ide a ako ste sa k nej dostali? Kedy ste zistili, že tras tela je funkčné riešenie pre ozdravný proces? Zaujalo ma to vyhorenie. Na stránke píšete, že ide o diagnózy s problematikou napätia, stresu, úzkostí, vyhorenia z hľadiska fyziológie aj psychológie. Vieme si k tomu ešte povedať viac?Koľko sa to človek musí učiť.. či je to pre deti aj dospelých.. prípadne seniorov... pre aké diagnózy je to overená metóda...)Techniku zaviedol Dr. David Berceli – ako sa k tomu vôbec dostal? Vieme niečo z histórie? Aké prípady z praxe by ste mohli menovať... Kde vás ľudia nájdu? TRE ® ponúka spôsob, ako zharmonizovať telesné fyziologické procesy a uvoľniť zátaž aj z rôznych starých „zranení“ bez potreby o danej problematike hovoriť. Aj s ukážkou "chvenia"Želám príjemné sledovanie. Ak chcete kontaktovať Evu, Link na web: https://www.metoda-tre.sk/ kupón VYHODNE pre lepšiu cenu v pokladni...Ďakujem, že ma podporujete na herohero alebo tu na YouTubeAj vďaka vám vzniká tento obsahChcete ma začať podporovať? Info tu: https://herohero.co/odznovaMnohí sa pýtate, kedy bude obsahu viac. Kedy bude tá miniTV Odznova.No bude, keď vás bude 2 000. Skôr neviem najať tím (kameraman + strihač + novinárka + korektorka...)Ja budem trpezlivá. Ale napadlo mi, že ak by každý zohnal 10-20 ľudí zo svojho okolia, tak by sa to mohlo podariť dosť skoro..Podpora je možná aj tu na YouTube.. zmysel to pre má od 5,99€ (50% z vášho predplatného mi zoberie YouTube ako províziu. Tak si to viete spočítať...) Predplatné 2,99 je bez nároku na obsah vopred. Ide len o sympatizovanie, za čo ďakujemAlebo aj na https://ko-fi.com/odznovapodcastAk nechcete platiť kartou, možné je podporovať aj cez číslo účtu: SK45 8330 0000 0022 0165 1060 - do poznámky uveďte, že ide o dar Chcete záznam z festivalu? LINK: https://www.budeakonebolo.sk/videozaznam-z-festivalu-odznova-v-pravdivosti-2024/

“Snažíme sa, aby mali vzťah nielen k firme, ale aj k tomu, čo robia. Keď ukončíme projekt, zamestnancov zoberieme, aby sa prišli pozrieť na výsledok, do ktorého robili súčiastky. Keď idú okolo stroja, uvedomia si, že ‘aha, toto je tá súčiastka, ktorú som vyrábal'. Je to pre nich najväčšia pochvala, keď vidia, že funguje niečo, čo vyrábali," hovorí.Čo ho v podnikaní najviac prekvapilo? “Prax, alebo život, je najlepší učiteľ. Mnoho poučiek, ktoré som si myslel, že budú platiť, neplatilo. Je to práca s ľuďmi, treba s nimi riešiť problémy. A zrazu som zistil, že polovica môjho pracovného času je práca s ľuďmi a psychológia a zrazu som mediátor a psychologický poradca.”Aj to sa dozviete v podcaste Prečo práve oni?, kde predstavujeme príbehy úspešných slovenských podnikateľov zo súťaže ⁠EY Podnikateľ roka⁠. Podcast vychádza každú stredu a moderuje ho Adela Vinczeová.

In dieser Episode spricht Anes Cavka über die größten Kostenfallen im Vertrieb – und wie man sie mit einfachen Mitteln umgeht.Aus über 180 Projekten im technischen Mittelstand zeigt er, wie Unternehmen durch gezielte Maßnahmen nicht nur Kosten senken, sondern gleichzeitig ihren Vertrieb effizienter und erfolgreicher aufstellen.

Immigrant Story Live (TIS), a month-long exhibit at PRAx, and a new OSU Press story collection, highlight the role of personal narrative in the telling of history and healing.

MUDr. Klímová: Psychosomatika, rodinné choroby, liečenie. Finálne diagnózy a riešenia. Prax. 2. diel Pokračovali sme v rozhovore s MUDr. Jarmilou Klímovou. Prešli sme si archetypy a aj to, ako sa stavať k diagnózam. Archetyp otca Archetyp matky Archetyp bytostné já Archetyp stínu Pani Klímová. Vy ste okrem iného napísali aj knihu Rakovina? Nie! Nemala som možnosť si knihu prečítať, ale niečo som už o nej započula. K napísaniu tejto knihy vás motivovala osobná skúsenosť s vynútenou diagnózou smrti. Ako si to máme vysvetliť? Mali ste rakovinu či nie? V knihe opisujete praktiky tzv. onkologickej lobby. Čo myslíte pod tou lobby? Ako sa má dnešný človek orientovať v tej spleti informácií a hlavne strachu? Dá sa vyviaznuť zdravý? Váš záverečný odkaz **** Ďakujem priatelia, že ma podporujete na herohero. https://herohero.co/odznova Prekročili sme prvú 100ku. Mnohí sa pýtate, kedy bude obsahu viac. Kedy bude tá miniTV Odznova. No bude, keď vás bude 2 000. Skôr neviem najať tím (kameraman + strihač + novinárka + korektorka...) Ja budem trpezlivá. Ale napadlo mi, že ak by každý zohnal 10-20 ľudí zo svojho okolia, tak by sa to mohlo podariť dosť skoro.. Podpora je možná aj tu na YouTube.. zmysel to pre má od 5,99€ (50% z vášho predplatného mi zoberie YouTube ako províziu. Tak si to viete spočítať...) Alebo aj na https://ko-fi.com/odznovapodcast Ak nechcete platiť kartou, možné je podporovať aj cez číslo účtu: SK45 8330 0000 0022 0165 1060 - do poznámky uveďte, že ide o dar Ak chcete Krásne dni Martina Valachová

RNDr. Jozef Valuch: Ruská škola hladovania ako liek? Ako hladovať správne? 2. diel a prax - prinášame odpovede na niektoré otázky a príbehy ľudí, ktorí na hladovke sú. ✍

Comenzamos el programa desde el Teatro de la Latina, donde hablamos con el elenco de 'Las Asambleístas (Las que tropiezan)'. Una adaptación de la comedia clásica de Aristófanes que reflexiona sobre las leyes, la injusticia y nuestro papel en la sociedad.Silvia Abril, Maite Sandoval, Pepa Zaragoza... Seis actrices que, lideradas por el personaje de Praxágora, deberán robar la ropa de los hombres y colarse en la asamblea para conseguir así cambiar las leyes establecidas por otras más justas e igualitarias. Una puesta en escena que invita a reflexionar sobre nuestro papel en la sociedad, obligándonos a implicarnos y tomar partido queramos o no. 

JP Finlay and Mitch Tischler join you from a soupy hot Miami that turned into a rainy lightning filled Miami for the Commanders and Dolphins joint practice. The Commanders fared much better in their second joint practice, with the offense showing some red zone efficiency and the defense showed an ability to get after the quarterback. Hear from Jahan Dotson, Ben Sinnott and Chris Rodriguez in this episode.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

JP Finlay and Mitch Tischler join you fresh off the first preseason game against the Jets to discuss a short, afternoon practice. The guys start by discussing some of the injuries across the team and how they'll affect evaluations before getting to some Miami prep and ending with JP's 1on1 with Ben SinnottSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

JP Finlay and Mitch Tischler join you from Florham Park, NJ, the home of the New York Jets practice facility and the site of the CommandersJets joint practice. The guys start off breaking down what they saw in practice today before getting to a couple of great interviews, first JP with Zach Ertz, then Mitch with Brycen Tremayne. Lastly they wrap with their one thing that involves kickers, and quarterbacks.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Elektrina „zadarmo“ zo Slnka znie ako dokonalé riešenie. Prax je ale oveľa zložitejšia. A hoci je táto téma naozaj komplexná, je možné vybrať niekoľko základných aspektov, na ktoré je dôležité sa zamerať pri uvažovaní o fotovoltike pre domácnosť. V podcaste SHARE ich zhrnuli redaktori Živé.sk Lukáš Koškár a Maroš Žofčin. V podcaste hovoríme aj o týchto témach: Za akých podmienok sa domácnosti inštalácia fotovoltiky oplatí.Aké zmeny v rodinnom režime si fotovoltika vyžaduje.Kedy sa oplatí investovať aj do fyzickej batérie.Ako je to s virtuálnou batériou a či je naozaj užitočná.Za akých podmienok sa dá fotovoltika využívať aj v zime.Ako návratnosť ovplyvňujú štátne dotácie a pre koho sú určené.Na čo si dať výber pri výbere firmy, ktorá fotovoltiku namontuje.Téme sa venujeme aj v týchto textoch:Kedy sa vám fotovoltika oplatí a kedy len mrháte peniazmi (+ako určiť správny výkon)Na čo si pri fotovoltike dávať pozor a kam umiestniť panely (+čo treba urobiť po inštalácii)Solárne panely sa líšia výkonom a najmä životnosťou. Južná orientácia nemusí byť jediná dobrá (rozhovor)Chcete od štátu tisíce eur na kotol, solárne panely či tepelné čerpadlo? Pozor na tieto pravidláPodcast SHARE pripravuje magazín Živé.sk.

Today we talk with more of both incumbents and fresh candidates for office. In hour one we'll talk with James Fields from Glennallen the Libertarian Candidate for Dist 36 (former Cronk seat). Then in hour two we'll chat with Mike Prax who's the incumbent representing North Pole and the surrounding area in House Dist 33.

The rumour mill has kicked into overdrive amid discussion that Repsol is considering the acquisition of NEO Energy, even while politics has overshadowed the energy sector. While some companies are moving away from the North Sea, others are choosing to stick it out, Ryan explains, on the basis that it can't get any worse. Prax has taken a similar line, signing a deal to buy assets from TotalEnergies in the Shetlands. The buyer has taken an innovative stance and now offers a smaller-scale integrated oil company, hoping that this will allow it to stay ahead of tough times. Shell has pressed pause on its ambitious SAF plans in Rotterdam this week, as the company's broader outlook for energy transition opportunities dims. The supermajor does still have enthusiasm for some transition opportunities, such as CCS, but with costs rising and the future uncertain, biofuel dreams are suffering.    About Energy Voice Energy Voice investigates and reports on what matters in global energy, helping sector leaders understand the geopolitical and economic factors underpinning current events, and giving them a view on what's coming over the horizon. Each year, 3.4m professionals use Energy Voice as a trusted source of breaking news and insight. For more information on how you can speak to those professionals across multiple platforms to build your brand and generate actionable business leads, visit energyvoice.com/content-services. For a 30 day free trial subscription to the Energy Voice website and app, visit energyvoice.com/subscribe.      

*Podcast Piatoček sa so svojím bizarným kvízom vyberá do regiónov. Ak si chcete overiť svoje vedomosti o postavičkách našej politiky, príďte v ⁠pondelok 24. júna do Milej Devy v Nitre⁠ a v utorok 25. júna do baru OOZI v Trnave. ⁠https://www.inviton.eu/e-16316/nitra-bizarny-politicky-kviz-s-piatockom⁠ ⁠https://www.inviton.eu/e-16319/trnava-bizarny-politicky-kviz-s-piatockom⁠ – Na pondelkový zápas Slovenska s Belgickom prišli aj politici. Namiesto niekoľko hodinovej cesty autom alebo komerčnou linkou, ich tam zaviezol vládny špeciál. Denník SME pohyb lietadla, ktoré sa s ministrami a so štátnymi tajomníkmi vrátilo po zápase naspäť, zistil z verejne dostupných databáz. Vláda totiž o ceste do Nemecka vôbec neinformovala. Kto všetko teda letel na zápas vládnym špeciálom, ako politici dnes aj v minulosti zamieňali pracovné cesty na súkromné výlety a kedy sa vôbec vládny špeciál môže využívať? Eva Frantová sa v podcaste Dobré ráno pýta Michala Katušku z domácej redakcie denníka SME. Zdroje zvukov: SME, TV JOJ, RTVS, TV Markíza Odporúčanie Ak nemáte to šťastie a na zápasy do Nemecka sa už tieto majstrovstvá nedostanete, pozrite si ich aspoň na diaľku. Slovensko ten najbližší hrá už zajtra o 15.00. Na ihrisku sa pritom stretne s Ukrajinou. – Všetky podcasty denníka SME nájdete na⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ sme.sk/podcasty⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ – Odoberajte aj audio verziu denného newslettra ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ SME.sk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ s najdôležitejšími správami na⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ sme.sk/brifing⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ – Odoberajte mesačný podcastový newsletter nielen o novinkách SME na ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠sme.sk/podcastovenovinky⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  – Ďakujeme, že počúvate podcast Dobré ráno.

JP Finlay and Mitch Tischler join you from Ashburn for week two of voluntary OTA's. The guys start by breaking down what they saw, and how it willcan impact the team, before giving you some great audio from Dan Quinn, Bobby Wagner and Marcus Mariota.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Clayton sits down with Dr Patrick Prax of Uppsala University to soak up his deep critical thinking about the systemic causes of and solutions to unsustainable practices in the games industry. Why aren't things moving faster? Who (or WHAT) is pushing in the other direction? What does it take to affect change not just to a game, a player base, a company, but an entire industry? LINKS: The Story of Stuff: ⁠https://www.youtube.com/@StoryofStuff⁠ IGDA Climate SIG: https://discord.gg/KW5XXWzCHq

Val talked about planting for pollinators, spring cleanup and more. --- Send in a voice message: https://podcasters.spotify.com/pod/show/wcmp-news/message

Dale Prax and Joe Lynch discuss preventing freight fraud. Dale is the Founder and CEO of FreightValidate, a carrier and freight broker identify verification and vetting system serving shippers, carriers, freight brokers. About Dale Prax Dale Prax is a dad, husband, grandfather, friend, mentor, Marine Corps veteran, inventor, innovator, disruptor, entrepreneur, fighter of fraud, freight executive, mobile app developer, freight rate analyst, philanthropist, and coach. Dale is the Founder of an Expedited Freight Brokerage company Direct Expedite. He also is the founder of two nonprofit organizations, a freight cost rating company, and a social media platform for freight professionals (FreightClub.us). His latest undertaking is FreightValidate, an identity and compliance verification system for shippers, freight brokers, motor carriers, load-boards, and factoring companies to verify that entities are in compliance with regulations and identify past, present, or potential fraudulent or double brokering threats. About FreightValidate FreightValidate is a carrier and freight broker identify verification and vetting system serving shippers, carriers, freight brokers, load-boards, and factoring companies. The FreightValidate platform ensures regulatory compliance and swiftly identifies any past, present, or potential fraudulent or double brokering threats within the industry. FreightValidate checks Motor Carrier Authority, DOT number validity, business location, and blocklisting history to flag potential fraud or non-compliance. Carriers are "Validated," "Not Validated," or given "Warning/Caution" statuses based on multiple data points. Key Takeaways: Preventing Freight Fraud FreightValidate is a carrier and freight broker identity verification and vetting system. They assist logistics businesses in mitigating risks and upholding compliance. FreightValidate utilizes advanced facial recognition technology for identity verification, reducing fraud and impersonation. The company serves shippers, brokers, carriers, and partners in the freight industry. FreightValidate provide improved transparency, minimized risk of identity theft, enhanced compliance with regulations. FreightValidate focues on compliance: Verifies licenses, insurance, and other vital information for carriers and brokers. FreightValidate collaborates with other companies like MyCarrierPortal to offer a broader range of services. They offer transparent pricing structure with various subscription plans tailored to different users. Learn More About Preventing Freight Fraud Dale Prax | Linkedin FreightValidate | Linkedin FreightValidate Direct: info@FreightValidate.com Sales: sales@FreightValidate.com The Logistics of Logistics Podcast If you enjoy the podcast, please leave a positive review, subscribe, and share it with your friends and colleagues. The Logistics of Logistics Podcast: Google, Apple, Castbox, Spotify, Stitcher, PlayerFM, Tunein, Podbean, Owltail, Libsyn, Overcast Check out The Logistics of Logistics on Youtube

Alex Nemiroff, General Counsel at Praxis Precision Medicines, focuses on developing life-altering treatments for pediatric patients with epilepsy, particularly those with genetic epilepsies known as Developmental Epileptic Encephalopathies- DEEs.  Praxis targets specific gene mutations SCN2A and SCN8A with therapies that precisely target the source of the disease. Lead drug candidate PRAX-562 is a precision small-molecule treatment that inhibits seizure-causing activity, and PRAX-222 is a type of RNA therapy that shows potential for complete disease modification. Alex explains, "There are a number of types of epilepsy. At Praxis, we focus on a few. We have a broader focal epilepsy program, and then we have a number of programs targeting these genetic epilepsies that are referred to as DEEs, Developmental Epileptic Encephalopathies. These are epilepsies that start in infancy, and they're tied most commonly to a mutation in a gene that is known to cause epilepsy. Specifically, we have at Praxis right now in the clinic, programs aimed at mutations in the SCN2A and SCN8A genes. So these are SCN2A DEEs and SCN8A DEEs."   "What we've tried to do, and it's been the goal of Praxis since its inception, since I got connected to this company, is to target these mutations as close to their source as possible. The name is Praxis Precision Medicines very intentionally because what we believe these medicines are doing is precisely targeting the source of the disease. Relatively speaking, as close as we can get. These are not gene therapies. What we have in our pipeline right now and in the clinic are RNA therapies, which are these antisense oligonucleotide therapies, and then also small molecules that are more precisely targeting key components of the diseases." "This is a big part of where the problem lies because the treatments that exist today, for the most part, are not precise to the specific cause of the disease. What we see with these genetic epilepsies- and again, specifically, we're focused on SCN2A and SCNA8A – there are no treatments other than the ones that Praxis are developing that target these mutations specifically. So what a doctor has to do, and what they did in my son's case and all of these other patients' cases, is they just start throwing these broad-based anti-epileptic medications at the child, and essentially, it's a trial and error process."  #Praxis #Epilepsy #PediatricEpilepsy #SCN2A #SCN8A #CNS praxismedicines.com Listen to the podcast here  

Alex Nemiroff, General Counsel at Praxis Precision Medicines, focuses on developing life-altering treatments for pediatric patients with epilepsy, particularly those with genetic epilepsies known as Developmental Epileptic Encephalopathies- DEEs.  Praxis targets specific gene mutations SCN2A and SCN8A with therapies that precisely target the source of the disease. Lead drug candidate PRAX-562 is a precision small-molecule treatment that inhibits seizure-causing activity, and PRAX-222 is a type of RNA therapy that shows potential for complete disease modification. Alex explains, "There are a number of types of epilepsy. At Praxis, we focus on a few. We have a broader focal epilepsy program, and then we have a number of programs targeting these genetic epilepsies that are referred to as DEEs, Developmental Epileptic Encephalopathies. These are epilepsies that start in infancy, and they're tied most commonly to a mutation in a gene that is known to cause epilepsy. Specifically, we have at Praxis right now in the clinic, programs aimed at mutations in the SCN2A and SCN8A genes. So these are SCN2A DEEs and SCN8A DEEs."   "What we've tried to do, and it's been the goal of Praxis since its inception, since I got connected to this company, is to target these mutations as close to their source as possible. The name is Praxis Precision Medicines very intentionally because what we believe these medicines are doing is precisely targeting the source of the disease. Relatively speaking, as close as we can get. These are not gene therapies. What we have in our pipeline right now and in the clinic are RNA therapies, which are these antisense oligonucleotide therapies, and then also small molecules that are more precisely targeting key components of the diseases." "This is a big part of where the problem lies because the treatments that exist today, for the most part, are not precise to the specific cause of the disease. What we see with these genetic epilepsies- and again, specifically, we're focused on SCN2A and SCNA8A – there are no treatments other than the ones that Praxis are developing that target these mutations specifically. So what a doctor has to do, and what they did in my son's case and all of these other patients' cases, is they just start throwing these broad-based anti-epileptic medications at the child, and essentially, it's a trial and error process."  #Praxis #Epilepsy #PediatricEpilepsy #SCN2A #SCN8A #CNS praxismedicines.com Download the transcript here  

Im ersten Teil der zweiten Folge mit Fritz B. Simon vertiefen wir den Unterschied zwischen Kybernetik 1. und 2. Ordnung. Zudem geht es um… … die Beobachtung der Suche nach selbst versteckten Ostereiern. … Simons Zusammenarbeit mit Watzlawick und von Foerster. … seine Arbeit in der Psychiatrie und Ausraster beim Kaffeetrinken. … inwiefern das, was funktioniert, systemisch ist. … keine typischen Kybernetiker-Typen. … 28-seitige Briefe und eine Hypothese für Watzlawicks ‚Hyperkorrektheit‘. … handgranatenartige Interventionen und Mustersprengung. … Reflexion, Irritation und Verstörung anstelle von Steuerung. Viel Freude beim Zuhören! „Cybernetics is a way of thinking, not a collection of facts.“ (Glasersfeld, 1992) Weiterführende Literatur und Links • Watzlawicks Kommunikationstheorie: Watzlawick, Beavin & Jackson (1969). Menschliche Kommunikation (8. Auflage, 1990). Bern: Huber. • Simons Veröffentlichung, durch die Watzlawick und von Foerster auf ihn aufmerksam geworden sind: Simon, Albert & Klein (1977): Gefahren paradoxer Kommunikation im Rahmen der „Therapeutischen Gemeinschaft“. Versuch einer Kommunikationsanalyse. Psychiat. Prax. 4, 1977, 38 – 43. • Zur Mailänder Gruppe, deren Entwicklung den Unterschied zwischen Kybernetik 1. und 2. Ordnung zeigt: Selvini-Palazzoli, Boscolo, Cecchin & Prata (1977). Paradoxon und Gegenparadoxon. Stuttgart: Klett-Cotta Verlag. • Glasersfelds Zitat „Cybernetics is a way of thinking, not a collection of facts.“ aus der Declaration der American Society for Cybernetics. Link: https://www.vonglasersfeld.com/065 • Lina Nagels Masterarbeit zum kybernetischen Konfliktverständnis: Nagel (2021). Kybernetik, Kommunikation und Konflikt. Gregory Bateson und (s)eine kybernetische Konflikttheorie. Link: https://www.carl-auer.de/kybernetik-kommunikation-und-konflikt • Tom Levolds Beitrag im Systemagazin „Um Himmels Willen, Margaret!“, in dem auf die erste Folge von „Cybernetics of Cybernetics“ Bezug genommen wird. Link: https://systemagazin.com/um-himmels-willen-margaret/

07:40 Птичек не жалко17:49 Поясни за жанр24:59 Разнесло в клочья34:10 Почему нравитсяRishloo — EidolonАльбом «Eidolon» в Apple Music, Spotify, YouTube Music, Tidal, DiscogsОсенний плейлистКлип Freaks & AnimalsПесниRishloo — Freaks & AnimalsRishloo — El EmpeRishloo — Alchemy AliceВсе права на музыку принадлежат законным правообладателям. Запись и сведение — Вадим Макеев. Джингл — Дэн Лебовиц. Фотография на обложке — Jérôme Prax.

#SyngapCensus https://www.syngapresearchfund.org/post/syngapcensus-2023-update-59-in-q3-2023-total-1-297 #UFDCure Cannonball - October 4-6 https://www.syngapresearchfund.org/cannonball Effie on CBall https://effieparks.com/podcast/effisode-074-syngap-cannonball-for-a-cure Pre-party https://x.com/UFDTech/status/1709366677261987862   Scramble - October 7, 2023 Stories https://www.syngapresearchfund.org/podcast-episodes/syngap1-stories-episode-019 Site https://www.syngapresearchfund.org/families/scramble-for-syngap-syngap-research-fund   PRAX-222 & ciitizen Marcio https://youtu.be/ibgINIFPFRk?si=Rtxe3rlTUWdMYGvg Pressers 9/20 https://www.prnewswire.com/news-releases/invitaes-real-world-ciitizen-data-utilized-in-praxis-precision-medicines-prax-222-ind-filing-301627677.html  10/2 https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-provides-portfolio-update-2023-rd-day    #mustread Essay by Jennifer: https://effieparks.com/blog/2023/9/30/sometimes-there-is-no-silver-lining  Book: https://www.amazon.com/Self-Compassion-Proven-Power-Being-Yourself/dp/0061733520/    Wild Type Campaign https://www.bonfire.com/wild-type-syngap1-1/    Conference - Sign up by Halloween - We need head counts. Registration link: https://Syngap.Fund/Orlando   Hotels: https://Syngap.Fund/2023hotel  Shirts: https://www.bonfire.com/srf-syngap1-conference-2023/  Share your time and blood too! Sign up for ciitizen! Sign up for CHOP! Volunteer! Give us 5 stars everywhere.  Like Apple podcasts: https://podcasts.apple.com/us/channel/syngap1-podcasts-by-srf/id6464522917   This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here - https://www.syngapresearchfund.org/syngap10-podcast Episode 118 of #Syngap10 - October 3, 2023 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GeneChat

Join us in this insightful episode of the ThinkFreight Podcast as we sit down with Dale Prax, the visionary founder of FreightValidate, to delve deep into the world of freight and transportation. In a candid conversation, Dale takes us on his journey, sharing how his passion for freight led him to establish FreightValidate and embark on a mission to transform the industry.We tackle a pressing concern that has been plaguing the freight landscape - the pervasive issue of double brokers. Dale sheds light on the magnitude of this problem and how it affects various stakeholders within the supply chain. As we navigate through the discussion, we uncover the challenges posed by double brokers and the potential ripple effects on the efficiency and reliability of freight operations.One of the hot-button topics of our conversation revolves around the role of regulatory bodies, specifically the FMCSA (Federal Motor Carrier Safety Administration), in addressing the double broker issue. Dale doesn't shy away from expressing his insights on why he believes more needs to be done and how the industry can work collaboratively with regulators to effect meaningful change.But that's not all – we dive even deeper into the realm of transportation with a frank discussion about insurance fraud. Dale walks us through the intricacies of insurance fraud within transportation and its far-reaching consequences. We explore the ways in which FreightValidate is at the forefront of combating this problem and safeguarding the integrity of the industry.Tune in and join us on this enlightening journey with Dale Prax and FreightValidate.Join our vibrant community of freight enthusiasts, and let's embark on this journey together

Seguindo nossa série de podcast direcionada a projetos de extensão universitária em circo, convidamos a Professora Elizandra Gacia da Silva, da Universidade Federal Fluminense, para falar sobre o projeto Prax-circense. Venha Conferir! Para saber mais:  https://www.instagram.com/prax.circense/ praxcircense@gmail.com Para conhecer um pouco mais sobre o Circus:https://linktr.ee/CircusFef

Benjamin Williams aka @Prax.Ben comes onto the show to discuss Libertarianism. 

The gals talked about the Master Gardeners Sale coming up at the Mora farmers Market May 27th from 8 to noon. --- Send in a voice message: https://podcasters.spotify.com/pod/show/wcmp-news/message

Welcome to the "Secrets of #Fail," a new pod storm series hosted by Matt Brown. In this series of 2023, Matt dives deep into the world of failures and lessons learned along the way from high-net-worth individuals.  Join Matt as he dives into the world of failures and lessons.Series: Secret of #FailAdi Y. Segal has extensive experience in the healthcare industry. In 2013, they worked as an Internal Consultant for The Leukemia & Lymphoma Society, where they helped research and reshape the organization's national programming efforts to increase access to care. In 2016, they were a Managing Entrepreneur in Residence at Mount Sinai Health System, where they led a team to create the first enterprise wide platform. In 2017, they were a Director of Business Operations & Clinic Partnerships at Genoa Healthcare Telepsychiatry, and also founded and served as Chief Executive Officer of SeeThru, where they built a platform that introduced price transparency to healthcare. In 2020, they were a Corporate Development at RxMx, a Managing Partner at Shulkin Ventures, and a Co-Founder & CEO at Prax. Currently, they are the CEO of Hapi.Get an interview on the Matt Brown Show: www.mattbrownshow.comSupport the show

We have a $20k match!  - https://syngap.fund/rdd23  - https://secure.givelively.org/donate/syngap-research-fund-incorporated/srf-rare-disease-day-2023   #Sprint4Syngap - https://syngap.fund/sprint23  - Main page https://secure.givelively.org/donate/syngap-research-fund-incorporated/sprint4syngap-2023  - 13 Teams! Four already raising funds: Team Tavilla, Team Naya, Hope4Hadley, Team Lizzy.  Nine more ready to go. - Bonfire Shirts: https://www.bonfire.com/sprint-for-syngap-2023/    Amazing Webinars - Brain Surgery - Done https://www.syngapresearchfund.org/webinars/69-syngap1-and-epilepsy-surgery-is-it-time-to-consider-a-different-toolbox  - Jeff Coller - mRNA - March 16th  https://www.syngapresearchfund.org/webinars/68-harnessing-messenger-rna-metabolism-for-the-development-of-precision-gene-therapy-syngap1  - Jillian McKee - Date TDB - https://syngap.fund/mckee    Killer Blogs on Free Genetic Testing - Simons https://www.syngapresearchfund.org/post/136-support-simons-searchlight-2023-campaign-sign-up - How to get testing https://www.syngapresearchfund.org/post/137-how-to-get-free-genetic-testing-for-people-with-autism-special-needs-epilepsy - Why it matters https://www.syngapresearchfund.org/post/138-why-getting-a-genetic-diagnosis-matters-especially-for-syngap1 - List of things to do this year! https://www.syngapresearchfund.org/post/139-srf-attended-advanced-therapies-week-in-miami-when-will-you-go-to-a-conference-for-syngap1    PRAX-222 Day! - https://twitter.com/cureSYNGAP1/status/1628189201232699393 - https://clinicaltrials.gov/ct2/show/NCT05737784?term=seizures&cond=Epilepsy&sfpd_s=02%2F08%2F2023&sfpd_d=14&sel_rss=new14   Syngap Stories is on! https://www.syngapresearchfund.org/syngap-stories    Ciitizen is over 200! Update your Ciitizen Records - Sign-IN https://app.ciitizen.com/  - Sign-UP https://ciitizen.com/syngap1    This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here  - https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts:  https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 94 of #Syngap10 - February 23,  2023  #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GeneChat

We have a $20k match! - https://syngap.fund/rdd23 - https://secure.givelively.org/donate/syngap-research-fund-incorporated/srf-rare-disease-day-2023 #Sprint4Syngap - https://syngap.fund/sprint23 - Main page https://secure.givelively.org/donate/syngap-research-fund-incorporated/sprint4syngap-2023 - 13 Teams! Four already raising funds: Team Tavilla, Team Naya, Hope4Hadley, Team Lizzy. Nine more ready to go. - Bonfire Shirts: https://www.bonfire.com/sprint-for-syngap-2023/ Amazing Webinars - Brain Surgery - Done https://www.syngapresearchfund.org/webinars/69-syngap1-and-epilepsy-surgery-is-it-time-to-consider-a-different-toolbox - Jeff Coller - mRNA - March 16th https://www.syngapresearchfund.org/webinars/68-harnessing-messenger-rna-metabolism-for-the-development-of-precision-gene-therapy-syngap1 - Jillian McKee - Date TDB - https://syngap.fund/mckee Killer Blogs on Free Genetic Testing - Simons https://www.syngapresearchfund.org/post/136-support-simons-searchlight-2023-campaign-sign-up - How to get testing https://www.syngapresearchfund.org/post/137-how-to-get-free-genetic-testing-for-people-with-autism-special-needs-epilepsy - Why it matters https://www.syngapresearchfund.org/post/138-why-getting-a-genetic-diagnosis-matters-especially-for-syngap1 - List of things to do this year! https://www.syngapresearchfund.org/post/139-srf-attended-advanced-therapies-week-in-miami-when-will-you-go-to-a-conference-for-syngap1 PRAX-222 Day! - https://twitter.com/cureSYNGAP1/status/1628189201232699393 - https://clinicaltrials.gov/ct2/show/NCT05737784?term=seizures&cond=Epilepsy&sfpd_s=02%2F08%2F2023&sfpd_d=14&sel_rss=new14 Syngap Stories is on! https://www.syngapresearchfund.org/syngap-stories Ciitizen is over 200! Update your Ciitizen Records - Sign-IN https://app.ciitizen.com/ - Sign-UP https://ciitizen.com/syngap1 This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here - https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 94 of #Syngap10 - February 23, 2023 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GeneChat --- Send in a voice message: https://podcasters.spotify.com/pod/show/syngap10/message

Koryos, Mannerbund, Proto-Indo Europeans, PIEs, pre-WWII view of PIEs, modern view of PIEs, Nazism, views on historic PIE culture, entheogens, similarities to Koryos chiefs & shamans, Krasnosamarskoe, sacrifice, animal sacrifice, dogs, PIE religion, spread of PIE culture via Koryos, association of Koryos with the dead, Halloween, longstanding ties between Koryos & wolves, the Wild Hunt, Koryos as an instrument of defusing intergenerational tension between younger and older men, Ephebos, Athens, Krypteia, Sparta, ancient Rome, Lupercalia, Arcadia, werewolf mythos, Pan Lykaios, Zeus Lykaios, Apollo Lykaios, wolf god of Rome & Greece, Faunus, Pan originally a wolf god, Fianna, Celtic mythology, role playing games, RPGs, Koryos in RPGs, dark connections to RPGs, The Cult of Prax, Greg Stafford, Glorantha, Steve Perrin, Society for Creative Anachronisms, Church of All World, Marion Zimmer Bradley, Leonard Lake, Walter Breen, Paul Doer, Zodiac killer, Skull and Bones, Mormonism, early Mormonism as modern Koryos, fundamentalist Mormonism as continuation, special operations forces, Joint Special Operations Command, Green Berets, US Special Operations CommandAfter first music break (3:30): Background of KoryosSecond music break (30:22): Historical examples of KoryosThird music break (1:08:23): Modern manifestations of the KoryosMusic by: Keith Allen Dennishttps://keithallendennis.bandcamp.com/Additional Music: Corwin Trailshttps://corwintrails.bandcamp.com/ Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

Val shares 4 upcoming events surrounding gardening, raising chickens and more. These are all free events. --- Send in a voice message: https://podcasters.spotify.com/pod/show/wcmp-news/message

JR's book, ORCA & RareX, Data talks, Update Ciitizen, Syndrome Management, ASOs for the Brain, Libby & Espy #S10e89   JR WEBINAR - MORE OF EVERYTHING - BOOK  - Thursday January 17, 2023 - https://syngap.fund/jr - Direct link: https://us02web.zoom.us/webinar/register/WN_EMzPKDWiRluBMmslT0wpdA    ORCA Progress and Rare-X - Sign up now and if signed up, take the ORCA.  - Login/Signup for Rare-X https://syngap1.rare-x.org/  - Take the ORCA   Ingo's CNS talk shows us what is possible with Ciitizen Data, other data.  And how distinct SYNGAP1 is… Thread https://twitter.com/JMGraglia/status/1612978647107002368 Distinct https://twitter.com/JMGraglia/status/1612978675053658113 SYBGAP1 Poster https://twitter.com/JillianLMcKee/status/1600202742269501442    Update your Ciitizen Records - Sign-IN https://app.ciitizen.com/   - Sign-UP https://ciitizen.com/syngap1    All about Syndrome Management, let's get beyond seizures. https://twitter.com/CNSdrughunter/status/1612863006148366356    PRAX-222 is number 3.  So exciting.  To see ASOs go into the Brain. Stoke with #SCN1A Ultragenyx with Angelman Syndrome Praxis with #SCN2A via #PRAX222 Who will 4 be?  Will it be #CDKL5?  #STXBP1? SYNGAP1?   Very special Wednesday Warrior, please read - 19 year olds https://twitter.com/cureSYNGAP1/status/1613263197930422272   Ellen's Dx Journey - 40 year old https://www.syngapresearchfund.org/post/131-is-it-genetic-my-40-year-journey-of-misdiagnoses-for-my-son    This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 89 of #Syngap10 - January 14,  2023  #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology

Garden Gab with Val Prax (12.21.22) --- Send in a voice message: https://anchor.fm/wcmp-news/message

Sportswashing. Prax prania vlastnej povesti a obrazu prostredníctvom športu. Nie je to však nejaký novodobý fenomén. V skutočnosti je to celkom starý trik, ktorý poznal napríklad aj Adolf Hitler a objavil ho Joseph Goebbels. No a v dnešnom podcastesa spoločne pozrieme na najslávnejší príklad sportswashingu v dejinách. Rok 1936 a Berlín, čas kedy nacisti uniesli olympijské hry a využili ich na vlastnú propagáciu. Podcastová verzia Dejepisu Inak vychádza v spolupráci s portálom ⁠⁠⁠⁠⁠⁠skpodcasty⁠⁠⁠⁠⁠⁠. Sledujte skpodcasty.sk na ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagrame⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ alebo ⁠⁠⁠⁠⁠⁠⁠LinkedIne⁠⁠⁠⁠⁠⁠⁠.

#InpatientOptimism is the appropriate feeling for this moment… #S10e84 Targeting Epilepsy Meeting at St. Jude: https://www.stjude.org/research/initiatives/pediatric-translational-neuroscience-initiative/targeting-epilepsy-translating-advances-in-research-to-genetic-epilepsy-therapy.html Praxis and PRAX-562 for #SCN2A and #SCN8A https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-advance-prax-562-phase-2-study Go Team Canada and Overcome for Bowie Small Molecule Grant! https://www.eurekalert.org/news-releases/960181 https://twitter.com/cureSYNGAP1/status/1597268138793762817?s=20&t=g1cxR6D2qqzIp-6-q6sY3g John Oldenhof, an #STXBP1 dad talks about two key points. https://www.biopharmaservices.com/blog/research-roundtable-for-epilepsy-a-reflection-by-dr-john-oldenhof/ #S10e83 on Stoke and TimeOnDrug https://www.youtube.com/watch?v=7uK2dCs53Ew #GivingTuesday - Support SRF! https://secure.givelively.org/donate/syngap-research-fund-incorporated/givingtuesday-2022 Genomenon: https://www.streetinsider.com/Press+Releases/Genomenon+Partners+with+Three+Rare+Disease+Foundations+to+Advance+Precision+Drug+Development/20904631.html Combined Brain: https://combinedbrain.org/ Thank you Heather and Spark! https://sparkforautism.org/discover_article/autism-answers-research/ https://twitter.com/cureSYNGAP1/status/1597348804021583872?s=20&t=g1cxR6D2qqzIp-6-q6sY3g This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 84 of #Syngap10 - November 29, 2022 #Syngap #SYNGAP1 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology --- Send in a voice message: https://podcasters.spotify.com/pod/show/syngap10/message

#ImpatientOptimism is the appropriate feeling for this moment… #S10e84 Targeting Epilepsy Meeting at St. Jude: https://www.stjude.org/research/initiatives/pediatric-translational-neuroscience-initiative/targeting-epilepsy-translating-advances-in-research-to-genetic-epilepsy-therapy.html Praxis and PRAX-562 for #SCN2A and #SCN8A https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-advance-prax-562-phase-2-study    Go Team Canada and Overcome for Bowie Small Molecule Grant! https://www.eurekalert.org/news-releases/960181 https://twitter.com/cureSYNGAP1/status/1597268138793762817?s=20&t=g1cxR6D2qqzIp-6-q6sY3g John Oldenhof, an #STXBP1 dad talks about two key points. https://www.biopharmaservices.com/blog/research-roundtable-for-epilepsy-a-reflection-by-dr-john-oldenhof/    #S10e83 on Stoke and TimeOnDrug https://www.youtube.com/watch?v=7uK2dCs53Ew    #GivingTuesday - Support SRF! https://secure.givelively.org/donate/syngap-research-fund-incorporated/givingtuesday-2022  Genomenon: https://www.streetinsider.com/Press+Releases/Genomenon+Partners+with+Three+Rare+Disease+Foundations+to+Advance+Precision+Drug+Development/20904631.html  Combined Brain: https://combinedbrain.org/  Thank you Heather and Spark! https://sparkforautism.org/discover_article/autism-answers-research/ https://twitter.com/cureSYNGAP1/status/1597348804021583872?s=20&t=g1cxR6D2qqzIp-6-q6sY3g  This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 84 of #Syngap10 - November 29,  2022  #Syngap #SYNGAP1 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology

Garden Gab with Val Prax --- Send in a voice message: https://anchor.fm/wcmp-news/message

A Conversation with Val Prax for Pork Producers (07.20.22) --- Send in a voice message: https://anchor.fm/wcmp-news/message

TELL EVERYONE - New mom chat - Kali's article and twitter      - https://www.insider.com/my-child-diagnosed-rare-genetic-condition-syngap1-2022-6       - https://twitter.com/WorthKali - Tavillas: https://syngap.fund/susan (6/22/15)   CHECK OUT THIS CONFERENCE: https://syngap.fund/treat   DRUG CO NEWS - Anglemans and Ionis! https://www.prnewswire.com/news-releases/ionis-treatment-for-angelman-syndrome-receives-orphan-drug-and-rare-pediatric-disease-designations-from-us-fda-301566169.html  - Praxis update: At the end, scroll down.    CIITIZEN - Webinar was awesome https://syngap.fund/virginie - Sign up! https://www.ciitizen.com/syngap1/   PROBABLY GENETIC IS WORKING! - Assessment:  syngap.fund/maybe - https://symptom-checker.probablygenetic.com/syngap/  - Webinar: https://syngap.fund/PG  - Sponsored testing with Mahzi! https://mahzi.com/    REMEMBER NOT TO MISS  - June 2022 https://mailchi.mp/syngapresearchfund.org/june22   - Sign up for the EF Panel: https://bit.ly/efmen      FUNDRAISERS - MDBR: Join us and secure $30k matching funds https://syngap.fund/SRFMDBR22   - MICE: Help us Make 2!  https://syngap.fund/2mice    EVENTS - June 25 in DFW - Join us for a family meeting and hear from Dr. Perry.  Link soon. - September 12-14 in San Diego - #GlobalGenes Meeting.  Link soon. - October 8 in NJ - Caren Leib Gala https://www.syngapresearchfund.org/get-involved/fundraising/caren-leib-gala  - October 8 in SC - Scramble for SYNGAP https://www.syngapresearchfund.org/get-involved/fundraising/scramble-for-syngap   - November 12 in GA - Sparks of Hope Gala https://syngap.fund/soiree  - December 1 in TN - Syngap Science Meeting - https://syngap.fund/treat    This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast   Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818    Episode 64 of #Syngap10 - June 14, 2022 #F78A1 #Syngap #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GlobalCollaboration #EpilepsyFoundation #Praxis #ProbablyGenetic #Mahzi   Copy from letter from Praxis: Monday morning, June 6th, we published an 8K filing announcing news involving multiple programs at Praxis Precision Medicines. One of these announcements pertained to the FDA's clinical hold on our recent IND filing for PRAX-222 in SCN2A, so we wanted to share further context for it. On May 25, 2022, the Company received a communication from the U.S. Food and Drug Administration (the “FDA”) providing additional information on the clinical hold placed on the Company's Investigational New Drug application (the “IND”) for the study of PRAX-222, an antisense oligonucleotide, for the treatment of patients with SCN2A gain-of-function mutations. The communication indicated that our IND could be cleared once we submit additional documentation related to the preclinical non-human primate toxicology study that supports the proposed starting dose in the clinical study. We're requesting a Type A meeting with the FDA to confirm the study design and further clarify the requirements for dose escalation beyond the starting dose. This surely will leave our SCN2A community with questions about the timing of our path forward. While the protocol and the discussions being held with the FDA remain confidential, we will do our best to maintain transparency and responsiveness throughout the process.     We continue to be fully committed to advancing PRAX-222 to clinical study. We also want to restate that this news is specific to PRAX-222, without impact on our PRAX-562 program for SCN2A, SCN8A and TSC. In Monday's press release, we reiterated our focus on driving toward proof of concept for PRAX-562. We'll provide further updates on PRAX-562 as we approach major milestones on this path. In addition, our other programs in PCDH19 and SYNGAP1 remain on-track.     Beyond epilepsy, Monday's 8K filing announced significant news pertaining to our Aria study of PRAX-114 in Major Depressive Disorder (MDD). It is with great regret that we announce the failure of the Aria Study, a study to determine the efficacy of a GABBA PAM extrasynaptic preference medicine to achieve fast-acting, lasting reduction of symptoms of MDD. After reviewing the data and our operational controls and observing failure to achieve our primary endpoint, we determined that PRAX-114 was indeed safe but not efficacious, and no further research and development of PRAX-114 is warranted. This conclusion has a negative impact on the study of PRAX-114 to treat Post-Traumatic Stress Disorder and Essential Tremor. This is a difficult decision for the Praxis team; but our commitment and capacity to researching and developing genetic insight-based treatments for people living with disorders of the CNS is in no way diminished.

Throw the doors open, build your team, tell everyone. #S10e64 TELL EVERYONE - New mom chat - Kali's article and twitter - https://www.insider.com/my-child-diagnosed-rare-genetic-condition-syngap1-2022-6 - https://twitter.com/WorthKali - Tavillas: https://syngap.fund/susan (6/22/15) CHECK OUT THIS CONFERENCE: https://syngap.fund/treat DRUG CO NEWS - Anglemans and Ionis! https://www.prnewswire.com/news-releases/ionis-treatment-for-angelman-syndrome-receives-orphan-drug-and-rare-pediatric-disease-designations-from-us-fda-301566169.html - Praxis update: At the end, scroll down. CIITIZEN - Webinar was awesome https://syngap.fund/virginie - Sign up! https://www.ciitizen.com/syngap1/ PROBABLY GENETIC IS WORKING! - Assessment: syngap.fund/maybe - https://symptom-checker.probablygenetic.com/syngap/ - Webinar: https://syngap.fund/PG - Sponsored testing with Mahzi! https://mahzi.com/ REMEMBER NOT TO MISS - June 2022 https://mailchi.mp/syngapresearchfund.org/june22 - Sign up for the EF Panel: https://bit.ly/efmen FUNDRAISERS - MDBR: Join us and secure $30k matching funds https://syngap.fund/SRFMDBR22 - MICE: Help us Make 2! https://syngap.fund/2mice EVENTS - June 25 in DFW - Join us for a family meeting and hear from Dr. Perry. Link soon. - September 12-14 in San Diego - #GlobalGenes Meeting. Link soon. - October 8 in NJ - Caren Leib Gala https://www.syngapresearchfund.org/get-involved/fundraising/caren-leib-gala - October 8 in SC - Scramble for SYNGAP https://www.syngapresearchfund.org/get-involved/fundraising/scramble-for-syngap - November 12 in GA - Sparks of Hope Gala https://syngap.fund/soiree - December 1 in TN - Syngap Science Meeting - https://syngap.fund/treat This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 64 of #Syngap10 - June 14, 2022 #F78A1 #Syngap #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GlobalCollaboration #EpilepsyFoundation #Praxis #ProbablyGenetic #Mahzi Copy from letter from Praxis: Monday morning, June 6th, we published an 8K filing announcing news involving multiple programs at Praxis Precision Medicines. One of these announcements pertained to the FDA's clinical hold on our recent IND filing for PRAX-222 in SCN2A, so we wanted to share further context for it. On May 25, 2022, the Company received a communication from the U.S. Food and Drug Administration (the “FDA”) providing additional information on the clinical hold placed on the Company's Investigational New Drug application (the “IND”) for the study of PRAX-222, an antisense oligonucleotide, for the treatment of patients with SCN2A gain-of-function mutations. The communication indicated that our IND could be cleared once we submit additional documentation related to the preclinical non-human primate toxicology study that supports the proposed starting dose in the clinical study. We're requesting a Type A meeting with the FDA to confirm the study design and further clarify the requirements for dose escalation beyond the starting dose. This surely will leave our SCN2A community with questions about the timing of our path forward. While the protocol and the discussions being held with the FDA remain confidential, we will do our best to maintain transparency and responsiveness throughout the process. We continue to be fully committed to advancing PRAX-222 to clinical study. We also want to restate that this news is specific to PRAX-222, without impact on our PRAX-562 program for SCN2A, SCN8A and TSC. In Monday's press release, we reiterated our focus on driving toward proof of concept for PRAX-562. We'll provide further updates on PRAX-562 as we approach m --- Send in a voice message: https://podcasters.spotify.com/pod/show/syngap10/message

CHECK OUT THIS CONFERENCE: https://syngap.fund/treat     PROBABLY GENETIC IS WORKING! - Assessment:  syngap.fund/maybe - https://symptom-checker.probablygenetic.com/syngap/   - Testing:  syngap.fund/ambit - https://www.ambitcare.com/registration-syngap-research-fund   - Webinar: https://syngap.fund/PG  - Thursday, June 9th at 9am PT/Noon ET/5pmBST   DON'T MISS OUR NEWSLETTER - June 2022 https://mailchi.mp/syngapresearchfund.org/june22 - Sign up https://www.syngapresearchfund.org/families/newsletters  - Please make sure we are not going to Spam   #FATHERHOOD & RARE - Sign up for the EF Panel: https://bit.ly/efmen - https://us06web.zoom.us/webinar/register/WN_Iv8d06ffT_uDbRDXAAWKOg    - SFN Dad To Dad Podcast: https://www.spreaker.com/user/specialfathers/dad-to-dad-204-mike-graglia     LINKS FORM EF #PIPELINECONFERENCE 2022 - Agenda: https://www.epilepsy.com/research-funding/pipeline-conference   - Kayak study for #SCN8A: https://kayakstudy.com/  - #Prax562: https://www.globenewswire.com/news-release/2022/01/18/2368578/0/en/Praxis-Precision-Medicines-Announces-Publication-of-Preclinical-Data-Highlighting-Differentiated-and-Potent-Antiepileptic-Activity-of-PRAX-562.html  - $PRAX https://seekingalpha.com/news/3845864-prax-stock-on-watch-as-lead-asset-fails-in-depression-trial  - Engrail: https://www.businesswire.com/news/home/20220607005544/en/Engrail-Therapeutics-Announces-Positive-Results-of-ENX-101-Phase-1b-Clinical-Study-and-Prepares-for-Initiation-of-ENACT-Phase-2-Trial-in-Focal-Epilepsy      FUNDRAISERS - MDBR: Join us and secure $30k matching funds https://syngap.fund/SRFMDBR22   - MICE: Help us Make 2!  https://syngap.fund/2mice    EVENTS June 11 in Philly - Support our team https://syngap.fund/srfmdbr22   June 25 in DFW - Join us for a family meeting and hear from Dr. Perry.  Link soon. September 12-14 in San Diego - #GlobalGenes Meeting.  Link soon. October 8 in NJ - Caren Leib Gala https://www.syngapresearchfund.org/get-involved/fundraising/caren-leib-gala  October 8 in SC - Scramble for SYNGAP https://www.syngapresearchfund.org/get-involved/fundraising/scramble-for-syngap   November 12 in GA - Sparks of Hope Gala https://syngap.fund/soiree  December 1 in TN - Syngap Science Meeting - https://syngap.fund/treat  EVERYONE SHOULD SIGN UP FOR CIITIZEN ASAP: https://www.ciitizen.com/syngap1/     This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast   Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818    Episode 63 of #Syngap10 - June 7, 2022 #F78A1 #Syngap #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GlobalCollaboration #EpilepsyFoundation #Engrail #Praxis #Neurocrine #ProbablyGenetic #AmbitHealthcare

CHECK OUT THIS CONFERENCE: https://syngap.fund/treat PROBABLY GENETIC IS WORKING! - Assessment: syngap.fund/maybe - https://symptom-checker.probablygenetic.com/syngap/ - Testing: syngap.fund/ambit - https://www.ambitcare.com/registration-syngap-research-fund - Webinar: https://syngap.fund/PG - Thursday, June 9th at 9am PT/Noon ET/5pmBST DON'T MISS OUR NEWSLETTER - June 2022 https://mailchi.mp/syngapresearchfund.org/june22 - Sign up https://www.syngapresearchfund.org/families/newsletters - Please make sure we are not going to Spam #FATHERHOOD & RARE - Sign up for the EF Panel: https://bit.ly/efmen - https://us06web.zoom.us/webinar/register/WN_Iv8d06ffT_uDbRDXAAWKOg - SFN Dad To Dad Podcast: https://www.spreaker.com/user/specialfathers/dad-to-dad-204-mike-graglia LINKS FORM EF #PIPELINECONFERENCE 2022 - Agenda: https://www.epilepsy.com/research-funding/pipeline-conference - Kayak study for #SCN8A: https://kayakstudy.com/ - #Prax562: https://www.globenewswire.com/news-release/2022/01/18/2368578/0/en/Praxis-Precision-Medicines-Announces-Publication-of-Preclinical-Data-Highlighting-Differentiated-and-Potent-Antiepileptic-Activity-of-PRAX-562.html - $PRAX https://seekingalpha.com/news/3845864-prax-stock-on-watch-as-lead-asset-fails-in-depression-trial - Engrail: https://www.businesswire.com/news/home/20220607005544/en/Engrail-Therapeutics-Announces-Positive-Results-of-ENX-101-Phase-1b-Clinical-Study-and-Prepares-for-Initiation-of-ENACT-Phase-2-Trial-in-Focal-Epilepsy FUNDRAISERS - MDBR: Join us and secure $30k matching funds https://syngap.fund/SRFMDBR22 - MICE: Help us Make 2! https://syngap.fund/2mice EVENTS June 11 in Philly - Support our team https://syngap.fund/srfmdbr22 June 25 in DFW - Join us for a family meeting and hear from Dr. Perry. Link soon. September 12-14 in San Diego - #GlobalGenes Meeting. Link soon. October 8 in NJ - Caren Leib Gala https://www.syngapresearchfund.org/get-involved/fundraising/caren-leib-gala October 8 in SC - Scramble for SYNGAP https://www.syngapresearchfund.org/get-involved/fundraising/scramble-for-syngap November 12 in GA - Sparks of Hope Gala https://syngap.fund/soiree December 1 in TN - Syngap Science Meeting - https://syngap.fund/treat EVERYONE SHOULD SIGN UP FOR CIITIZEN ASAP: https://www.ciitizen.com/syngap1/ This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://podcasts.apple.com/us/podcast/syngap10-weekly-10-minute-updates-on-syngap1-video/id1560389818 Episode 63 of #Syngap10 - June 7, 2022 #F78A1 #Syngap #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #GlobalCollaboration #EpilepsyFoundation #Engrail #Praxis #Neurocrine #ProbablyGenetic #AmbitHealthcare --- Send in a voice message: https://podcasters.spotify.com/pod/show/syngap10/message

In an attempt to invite people into my Launch Team for Prax (coming April 2022!), we discovered that most people - including authors and Bookstagrammers - have no idea what a Launch Team even is!Well, we are about to fix that.And when I say "we", I really mean me, Nikki Auberkett, and my co-host, Quill (who tried to edit this episode by deleting 80% of it).Check out the new company, and new website, at www.talaeditorial.comFollow us on Instagram @thetalaeditorialAnd, as always, follow your favorite developmental editor on Instagram @nikkiauberkettWant to join the Prax Launch Team and get exclusive behind-the-scenes updates, early access to the ebook, and a signed copy - all for FREE? Sign up here at bit.ly/Prax2022

What does it take to decide to live life to the fullest? We all work so hard today to fund our dream retirement but what if I tell you it's possible to do it even in your working years? What if you could retire in your mid-20s? For the married couple Nicole and Prax, nothing is impossible. They decided to do a mini-retirement after getting married and committed to do this every decade until their real retirement age. I actually booked my mini retirement after the first time I heard their story! Follow them on their socials: @nicoleandprax Follow me on my socials: @coachyanimoya @quarterlifeblisspodcast Youtube: youtube.com/yanimoya Website: www.yanimoya.com

- Patreon: https://www.patreon.com/anaminecan - Curso completo: https://www.anaminecan.com/artegriego

President and CEO of Praxis Precision Medicines (PRAX) Marcio Souza joins The Watch List one year following the company's public listing. Souza talks about how the biopharmaceutical company is attempting to combat the mental health crisis overtaking the U.S. Praxis develops therapies for central nervous system disorders characterized by neuronal imbalance like major depressive disorder and posttraumatic stress disorder.

The Zax by Dr Seuss A story from the book The Sneetches and Other Stories features The Zax from the Dr. Seuss book. They are stubborn and arguable and have messy hair and hairy bodies. They live in the Prairie of Prax. Varieties of Zax include a North-Going Zax and a South-Going-Zax. Due to their stubbornness, they refuse to go in any direction other than their assigned directions. If a south-going Zax encounters a north-going Zax, they cannot solve their issue and the world progresses without them as years pass by, such as a highway being built over them and a city nearby while still standing grumpily at each other. https://seuss.fandom.com/wiki/The_Zax

Music. Magic. Mystery. Who is that girl? What's with that violin? Join the party bard, Parker Prax, as he seeks the muse to his magic and becomes fracture fated! >>>>> This is the final of our prologue episodes. In 2 weeks, the campaign begins in earnest! Get ready for Episode 1 to drop!

LSU football held its annual team banquet Monday where it handed out individual awards.  Devin White was named MVP and we reacted to all the awards handed out.  Also, the Tigers were back on the practice field and the coaching staff continues hiding the safeties from the media.  We wrapped up with a Mailbag segment that included your questions about Signing Day, Baseball and even Gymnastics. Learn more about your ad choices. Visit podcastchoices.com/adchoices